ProCE Banner Activity

CE / CME

Elevating Patient Care in MDD: Switching and Augmentation Strategies

Video

On-demand webcast of expert faculty presentation and case discussion on switching and agumentation strategies for improving patient outcomes among those with major depressive disorder.

Nurses: 1.50 Nursing contact hours

Physicians: maximum of 1.50 AMA PRA Category 1 Credits

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Released: October 08, 2024

Expiration: October 07, 2025

Share

Faculty

Lisa Harding

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Terrell D. Holloway

Terrell D. Holloway, MD

Clinical Instructor
Yale School of Medicine
Department of Psychiatry
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Target Audience

This program is intended for healthcare professionals caring for patients with major depressive disorder, particularly family physicians, physician associates, nurse practitioners, registered nurses, and other healthcare professionals in primary care and family practice settings.

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with depression.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Summarize criteria that determine when to switch or augment medications in MDD based on best practices

  • Interpret the emerging evidence for the use of antipsychotics in the treatment of MDD

  • Select an evidence-based augmentation agent for a patient with MDD

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Lisa Harding, MD: consultant/advisor/speaker: Compass Pathways, Janssen Scientific Affairs, Otsuka.

Terrell D. Holloway, MD

Clinical Instructor
Yale School of Medicine
Department of Psychiatry
New Haven, Connecticut

Terrell D. Holloway, MD: consultant/advisor/speaker: Janssen Scientific.

Joseph F. Goldberg, MD: consultant/advisor/speaker: AbbVie, Alkermes, Axsome, Bristol Myers Squibb, Intracellular Therapies, Lundbeck, Luye Pharmaceuticals, Neurelis, Neumora, Otsuka, Supernus.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Michael Asbach, DMSc, PA-C as noted below:​

Michael Asbach, DMSc, PA-C: consultant/advisor/speaker: AbbVie, Avanir, Intra-Cellular, Janssen, Neurocrine, Otsuka, Sage/Biogen.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 08, 2024, through October 07, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.  

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until October 07, 2025. PAs should only claim credit commensurate with the extent of their participation.

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

AAFP Approval Statement: 
The AAFP has reviewed Elevating Patient Care in MDD through Comprehensive Adjunctive Strategies - Enduring and deemed it acceptable for up to 1.50 Enduring Material, Self-Study AAFP Prescribed credit(s). Term of Approval is from 10/08/2024 to 10/07/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.